Effects of metallothionein-3 and metallothionein-1E gene transfection on proliferation, cell cycle, and apoptosis of esophageal cancer cells

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 4595-4603

  Tian, Z Q ^a   Xu, Y Z ^a   Zhang, Y F ^a   Ma, G F ^a   He, M ^a   Wang, G Y ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Flow cytometry; Gene transfection; MT 1E; MT 3; Proliferation

Indexed keywords

LIPOSOME; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN IE; METALLOTHIONEIN III; UNCLASSIFIED DRUG; GROWTH INHIBITOR; METALLOTHIONEIN; METALLOTHIONEIN 1E PROTEIN, HUMAN; NERVE PROTEIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ESOPHAGUS CANCER; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HUMANS; METALLOTHIONEIN; NERVE TISSUE PROTEINS; TRANSFECTION;

EID: 84886878267     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.17.2     Document Type: Article

References (12)

1. Cherian MG, Jayasurya A and Bay BH (2003). Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. 533: 201-209.
2. Garrett SH, Sens MA, Shukla D, Nestor S, et al. (1999). Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. Prostate 41: 196-202.
3. Guo Q and Tian ZQ (2010). Penetration effectiveness of air-to-ground, the different subtypes of metallothionein mRNA in esophageal squamous cell carcinoma. Pract. Oncol. 25: 519-522.
4. Hishikawa Y, Koji T, Dhar DK, Kinugasa S, et al. (1999). Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus. Br. J. Cancer 81: 712-720.
5. Miles AT, Hawksworth GM, Beattie JH and Rodilla V (2000). Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 35: 35-70.
6. Sens MA, Somji S, Lamm DL, Garrett SH, et al. (2000). Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ. Health Perspect. 108: 413-418.
7. Sens MA, Somji S, Garrett SH, Beall CL, et al. (2001). Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. Am. J. Pathol. 159: 21-26.
8. Smith E, Drew PA, Tian ZQ, De Young NJ, et al. (2005). Metallothionien 3 expression is frequently down-regulated in oesophageal squamous cell carcinoma by DNA methylation. Mol. Cancer 4: 42.
9. Sun XF, Du JJ and Meng L (2006). Metallothionein expression in esophageal squamous cell carcinoma and its relationship apoptosis and proliferation. Sin. Shandong Univ. 44: 384-388.
10. Tian ZQ and Liu JF (2004). Penetration effectiveness of air-to-ground, such as esophageal squamous cell carcinoma of the MT-3 gene CpG island methylation and its clinical significance. Pract. Oncol. 19: 386-389.
11. Tian ZQ, Wang XL and Wu W (2008). Metallothionein expression in esophageal carcinoma and its relationship with the expression of metallothionein 1 and 2. Cancer 27: 160-164.
12. Zhou B, Yang W, Ji JG and Bing-Gen RU (2003). Transiently transfected metallothionein-3 gene posterity neuroblastoma cell line SH-SY5Y cell proteins differentially expressed. Biochem. Biophys. 35: 522-528.